Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1996
Business Overview: The Company provides medical imaging and therapy services, including MRI, CT, Nuclear Medicine, Ultrasound, Respiratory Therapy, and Gamma Knife services. Operations involve mobile routes and interim rentals.
Key Financial Metrics
| Metric | Q1 1996 | Q1 1995 |
|---|---|---|
| Revenues (Medical Services) | $8,939,000 | $8,672,000 |
| Total Costs and Expenses | $9,488,000 | $10,058,000 |
| Net Loss | ($480,000) | ($1,283,000) |
| Net Loss Per Share | ($0.11) | ($0.45) |
| Cash and Cash Equivalents (End of Period) | $510,000 | $742,000 |
| Net Cash Provided by Operating Activities | $2,398,000 | $1,801,000 |
| Total Assets | $32,680,000 | N/A |
| Total Liabilities | $43,735,000 | N/A |
| Stockholders' Equity (Net Capital Deficiency) | ($11,055,000) | N/A |
| Working Capital Deficiency | ($8,813,000) | N/A |
Note: Total Liabilities calculated as Total Assets minus Net Capital Deficiency.
Material Changes vs. Prior Period
- Revenue Growth: Medical services revenue increased by $267,000 (3.1%). MRI revenue rose $920,000 (15%) due to new contracts and higher utilization. This was offset by declines in Respiratory Therapy ($412,000 decrease), Nuclear Medicine/Ultrasound ($122,000 decrease), and Gamma Knife ($95,000 decrease).
- Expense Reduction: Total costs decreased by $570,000 compared to the prior year. Interest expense dropped significantly by $674,000 following the repurchase of Senior Subordinated Notes in May 1995. Depreciation and amortization decreased by $679,000 due to the adoption of FAS 121 and lease term extensions.
- Profitability Improvement: Net loss narrowed from $1,283,000 in Q1 1995 to $480,000 in Q1 1996.
- Asset Sales: The Company sold Modesto buildings for $650,000 cash in March 1996, proceeds used to reduce revolving credit borrowings.
Outlook, Risks, and Management Commentary
- Going Concern Warning: Management states there is "substantial doubt" about the Company's ability to continue as a going concern. The Company has a net capital deficiency of $11,055,000 and insufficient cash resources to repay debt obligations at maturity without new financing.
- Liquidity Strategy: To meet obligations, management plans to reduce expenses, sell non-essential assets, negotiate with creditors, increase revenue, and potentially exchange equity for debt. There is no assurance these measures will succeed.
- Debt Obligations: The Company remains highly leveraged. Scheduled payments for the 12 months ending Dec 31, 1996, include $8,313,000 in capital lease payments, $834,000 in operating lease payments, and approximately $4,824,000 in other debt principal and interest.
- Restructuring: Recent lease and note restructurings (Dec 1995/March 1996) deferred payments and reduced 1996 cash requirements by approximately $1,200,000, curing outstanding defaults.
- Bankruptcy Risk: Failure to meet obligations could lead to asset seizure and force the Company into Chapter 7 liquidation or Chapter 11 reorganization.
Investor Verification Checklist
- Verify the availability and terms of new financing required to meet upcoming debt maturities.
- Confirm the status of the $1,200,000 payment reduction from recent lease restructurings and whether further concessions are secured.
- Monitor the execution of the asset sale program to generate necessary liquidity.
- Assess the sustainability of MRI revenue growth versus the decline in Respiratory Therapy and other service lines.
- Review the Company's ability to maintain compliance with debt covenants given the high leverage and working capital deficiency.